Henry Brem

Henry Brem. He is a pioneering American neurosurgeon and oncologist renowned for his transformative work in the treatment of malignant glioma and other brain cancers. As the Director of the Department of Neurosurgery at the Johns Hopkins Hospital and a professor at the Johns Hopkins University School of Medicine, his career has been dedicated to advancing surgical techniques and developing novel drug delivery systems. Brem's leadership in translational research has bridged the gap between laboratory discovery and clinical application, significantly improving outcomes for patients with complex neurological diseases.

Early life and education

Brem was born in New York City and developed an early interest in medicine and science. He pursued his undergraduate education at Columbia University, where he earned a degree in biochemistry. He then attended Harvard Medical School, receiving his M.D. degree and graduating with honors. His postgraduate training included a surgical internship at the New York Hospital-Cornell Medical Center, followed by a residency in neurological surgery at the New York Neurological Institute. This foundational period solidified his commitment to tackling the most challenging problems in neurosurgery and cancer research.

Career and research

Brem's entire professional career has been centered at the Johns Hopkins Hospital, where he joined the faculty and eventually became the Harvey Cushing Professor of Neurosurgery. His seminal research, conducted in collaboration with biomedical engineers like Robert Langer of the Massachusetts Institute of Technology, focused on localized chemotherapy for brain tumors. This work led to the co-invention and clinical development of the Gliadel wafer, a biodegradable polymer implant that delivers carmustine directly to a tumor resection cavity, which received approval from the U.S. Food and Drug Administration. He also founded and directs the Hunterian Neurosurgical Research Laboratory, a hub for innovation in drug delivery systems, antiangiogenic therapy, and immunotherapy for central nervous system malignancies. Under his leadership, the Johns Hopkins Department of Neurosurgery has remained at the forefront of treating cerebral aneurysms, Parkinson's disease, and pituitary tumors.

Honors and awards

Brem has received numerous prestigious accolades for his contributions to medicine and science. He is a recipient of the Jacob K. Javits Neuroscience Investigator Award from the National Institute of Neurological Disorders and Stroke. The American Association of Neurological Surgeons awarded him its highest honor, the Cushing Medal, for exceptional service to the field. His innovative research has also been recognized by the American Academy of Neurology and the Society for Neuro-Oncology. Furthermore, he has been elected to membership in esteemed organizations such as the American Surgical Association and the Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine.

Personal life

Brem is known to maintain a private personal life, with his public focus remaining on his clinical, research, and educational missions at Johns Hopkins University. He is actively involved in mentoring the next generation of neurosurgeons and scientists through his roles at the Johns Hopkins University School of Medicine and various national committees. His dedication to patient care and advancing the frontiers of neurosurgical oncology continues to define his professional legacy.

Selected publications

Brem's extensive research output includes hundreds of peer-reviewed articles and book chapters. Key publications often focus on clinical trials and innovative therapies, such as "Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas" in *The Lancet*. Other significant works include "Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas" in the *Journal of Neurosurgery* and studies on bevacizumab for recurrent glioblastoma in the *New England Journal of Medicine*. His publications are frequently cited in the fields of neuro-oncology and biomedical engineering. Category:American neurosurgeons Category:American oncologists Category:Johns Hopkins University faculty Category:Harvard Medical School alumni Category:Columbia University alumni